Ali Aqamolaei

Ketamine and Other Glutamate Receptor Modulating Agents for Treatment-Resistant Depression: A Systematic Review of Randomized Controlled Trials

S. Akhondzadeh, A. Shamabadi, A. Hasanzadeh, 2022, Iranian journal of psychiatry.

Comparison of vortioxetine and sertraline for treatment of major depressive disorder in elderly patients: A double‐blind randomized trial

S. Akhondzadeh, M. Shalbafan, Leila Kamalzadeh, 2020, Journal of clinical pharmacy and therapeutics.

Cinnamomum tamala as an adjuvant therapy in the treatment of major depressive disorder: A double-blind, randomized, placebo-controlled clinical trial with placebo control

S. Akhondzadeh, B. Daraei, A. Jamshidi, 2020 .

L-Carnosine combination therapy for major depressive disorder: A randomized, double-blind, placebo-controlled trial.

S. Akhondzadeh, M. Shalbafan, M. E. Ardebili, 2020, Journal of affective disorders.

Crocus sativus L. Versus Methylphenidate in Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Pilot Study.

M. Mohammadi, S. Akhondzadeh, E. Khadem, 2019, Journal of child and adolescent psychopharmacology.

5-Hydroxytryptophan as adjuvant therapy in treatment of moderate to severe obsessive-compulsive disorder: a double-blind randomized trial with placebo control

S. Akhondzadeh, S. B. Mousavi, R. Alikhani, 2020, International clinical psychopharmacology.

Amantadine as adjuvant therapy in the treatment of moderate to severe obsessive–compulsive disorder: A double‐blind randomized trial with placebo control

S. Akhondzadeh, Erfan Sahebolzamani, Ali Aqamolaei, 2018, Psychiatry and clinical neurosciences.